Lv4
434 积分 2023-04-27 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
14小时前
待确认
IgA Nephropathy in Adults
1天前
已完结
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY Trial
1天前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1天前
已完结
Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy
1天前
已完结
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers
1天前
已完结
Narsoplimab: First Approval
1天前
已完结
Sibeprenlimab: First Approval
1天前
已完结
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
3天前
已完结
Therapeutic strategies for hepatitis B virus infection: towards a cure
3天前
已完结
皖公网安备34019202002308
